Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: J Allergy Clin Immunol. 2015 Jul 2;136(6):1548–1558.e7. doi: 10.1016/j.jaci.2015.05.024

Table I.

Subjects' characteristics

Control CRSsNP CRSwNP
Total no. of subjects 37 (18M) 47 (23M) 84 (57M)
Age (y), median (range) 48.5 (16-78) 38 (20-71) 45(23-74)
Y N U Y N U Y N U
Atopy 4 31 2 24 15 8 42 27 15
Asthma 0 36 1 11 34 2 35 47 2
PCR Uncinate Uncinate Uncinate Polyp
No. of subjects 18 (8M) 23 (8M) 23 (17M) 20 (18M)
Age (y), median (range) 46 (16-62) 36 (20-64) 43 (27-56) 43 (26-74)
NEC PCR
No. of subjects 13 (6M) 15 (8M) 15 (10M) 22 (17M)
Age (y), median (range) 41(29-75) 36 (21-64) 52 (35-67) 49 (27-72)
Immunoblot
No. of subjects 9 (5M) 12 (7M) 10 (6M) 17 (6M)
Age (y), median (range) 61 (20-78) 46 (20-71) 49 (32-71) 45 (23-70)

M:male, Y:yes, U: unknown, NEC: nasal epithelial cells